# Safety of Fluvastatin-Celebrex Association in Low-grade and High Grade Optico-chiasmatic Gliomas

> **NCT02115074** · PHASE1 · COMPLETED · sponsor: **Centre Oscar Lambret** · enrollment: 20 (actual)

## Conditions studied

- Glioma

## Interventions

- **DRUG:** Fluvastatine
- **DRUG:** Celebrex

## Key facts

- **NCT ID:** NCT02115074
- **Lead sponsor:** Centre Oscar Lambret
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-06
- **Primary completion:** 2018-11
- **Final completion:** 2022-01
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2026-03-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02115074

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02115074, "Safety of Fluvastatin-Celebrex Association in Low-grade and High Grade Optico-chiasmatic Gliomas". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT02115074. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*